Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer

In this study, we developed a catalog of biliary tract cancer PDXs that underwent comprehensive molecular profiling and therapeutic modeling. To date, this is one of the largest collections of biliary tract cancer PDX models and will facilitate the development of personalized treatments for patients with these aggressive malignancies.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2024-11-08
DOI
https://doi.org/10.1158/1078-0432.ccr-24-1233
Citations
1
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
0.57

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer

Yasmeen Q. Rizvi, Michael Kahle, Hop S. Tran Cao, Kurt W. Evans et al.
1 citations
Clinical Cancer Research
Cholangiocarcinoma and Gallbladder Cancer Studies
0.57
article

Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer

Yasmeen Q. Rizvi, Michael Kahle, Hop S. Tran Cao, Kurt W. Evans, Timothy P. DiPeri, Jordi Rodón, Thuy M. Vu, Lawrence N. Kwong, Milind M. Javle, Sunyoung S. Lee, Fei Su, Timothy Anthony Yap, Maria Gabriela Raso, Funda Meric‐Bernstam, Ching‐Wei D. Tzeng, Xiaofeng Zheng, Kaushik Varadarajan, Ming Zhao, Sun-Hee Kim, Huamin Wang, Stephen Scott
article en
1 citations

Abstract

In this study, we developed a catalog of biliary tract cancer PDXs that underwent comprehensive molecular profiling and therapeutic modeling. To date, this is one of the largest collections of biliary tract cancer PDX models and will facilitate the development of personalized treatments for patients with these aggressive malignancies.

Clinical Cancer ResearchVol. 31(2)
The University of Texas MD Anderson Cancer Center (US), Loyola University Chicago (US)
National Institutes of Health, University of Texas MD Anderson Cancer Center, National Cancer Institute
Openalex Percentile: Top 28%
Cholangiocarcinoma and Gallbladder Cancer Studies
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.